DRAVP
  1. Home
  2. Browse
  3. Classified Browse
  4. Back
DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01269 HR1-1(HR1 region 889–926) NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA SARS-CoV 15184046
DRAVPe01270 HR2-18(HR2 region 1161–1187) IQKEIDRLNEVAKNLNESLIDLQELGK SARS-CoV 15184046
DRAVPe01290 HR1-a(899-926) YENQKQIANQFNKAISQIQESLTTTSTA SARS-CoV 18442051
DRAVPe01291 GST-removed HR2(1145-1192) DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI SARS-CoV 18442051
DRAVPe01292 sHR2-1(derived from SARS-CoV spike protein heptad repeat) ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01293 sHR2-2(derived from SARS-CoV spike protein heptad repeat) PKEELDKYFKNHTSPDVDLGLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01294 sHR2-3(derived from SARS-CoV spike protein heptad repeat) LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01295 sHR2-4(derived from SARS-CoV spike protein heptad repeat) FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01296 sHR2-5(derived from SARS-CoV spike protein heptad repeat) TSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01297 sHR2-6(derived from SARS-CoV spike protein heptad repeat) VDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01298 sHR2-7(derived from SARS-CoV spike protein heptad repeat) DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 15150417
DRAVPe01299 sHR2-8(derived from SARS-CoV spike protein heptad repeat) ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK SARS-CoV 15150417
DRAVPe01300 sHR2-9(derived from SARS-CoV spike protein heptad repeat) ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL SARS-CoV 15150417
DRAVPe01301 sHR2-10(derived from SARS-CoV spike protein heptad repeat) ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLID SARS-CoV 15150417
DRAVPe01302 mHR2(derived from SARS-CoV spike protein heptad repeat) DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE SARS-CoV 15150417
DRAVPe01303 Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals) ATCYCRTGRCATRESLSGVCEISGRLYRLCCR SARS-CoV-2,HSV,HIV 34206990,26206286,23269800
DRAVPe01416 SARSWW-I(770-788) MWKTPTLKYFGGFNFSQI SARS-CoV 16616792
DRAVPe01417 SARSWW-II(864-886) ATAGWTFGAGAALQIPFAMQMAY SARS-CoV 16616792
DRAVPe01418 SARSWW-III(1028-1049) GYHLMSFPQAAPHGVVFLHVTW SARS-CoV 16616792
DRAVPe01419 SARSWW-IV(1075-1093) GVFVFNGTSWFITQRNFFS SARS-CoV 16616792
DRAVPe01420 SARSWW-Vb(1169-1194) AACEVAKNLNESLIDLQELGKYEQYIKW SARS-CoV 16616792
DRAVPe01421 MHVWW-IV(1144-1162) GYFVQDDGEWKFTGSSYYY SARS-CoV 16616792
DRAVPe01627 P1(ACE2 (4-13)) EEQAKTFLDK SARS-CoV 16510163
DRAVPe01628 P2(ACE2 (12-20)) DKFNHEAED SARS-CoV 16510163
DRAVPe01629 P3(ACE2 (15-23)) NHEAEDLFY SARS-CoV 16510163
DRAVPe01630 P4(ACE2 (4-26)) EEQAKTFLDKFNHEAEDLFYQSS SARS-CoV 16510163
DRAVPe01631 P5(ACE2 (4-39)) EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE SARS-CoV 16510163
DRAVPe01632 P6(ACE2 (4-26)-G-ACE2 (333-339)) EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR SARS-CoV 16510163
DRAVPe01653 Peptide 2 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01654 Peptide 3 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
First 1 2 3 4 5 6 Last
CC0 To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.